✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Sino Biopharmaceutical Ltd

Common Name
Sino Biopharmaceutical
Country
Hong Kong
Sector
Healthcare
Industry
Biotechnology
Employees
23,056
Ticker
1177
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The compan...

Disclosures of Sino Biopharmaceutical

Explore Sino Biopharmaceutical's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Sino Biopharmaceutical's official channels and fully traceable to its official company sources.

The table below lists all of Sino Biopharmaceutical's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Sino Biopharmaceutical's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Annual Report
2024
ESG Report
2024
Annual Report
2023
ESG Report
2023
Annual Report
2022
ESG Report
2022
Financial & Extra-Financial Disclosure
2021
Annual Report
2021
ESG Report
2021
ESG Report
2020
Annual Report
2020
ESG Report
2019
Annual Report
2019
ESG Report
2018
Annual Report
2018
Annual Report
2017
Annual Report
2016
Annual Report
2015
Annual Report
2014
Annual Report
2013
Annual Report
2012
Annual Report
2011
Annual Report
2010
Annual Report
2009
Annual Report
2008
Annual Report
2007
Annual Report
2006
Annual Report
2005
Annual Report
2004
Annual Report
2003
Annual Report
2002
Annual Report
2001
Annual Report
2000
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?